Innovision Limited Re-files Director Resignation Documents After Exchange Observation

2 min read     Updated on 09 Apr 2026, 03:39 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Innovision Limited re-submitted regulatory filings regarding Ms. Sudha Hooda's resignation as Independent Director following an exchange observation about documentation placement. The company clarified that while the resignation letter was uploaded in the Change in Management section, it was inadvertently omitted from the Director Resignation disclosure section, prompting the re-filing on 08th April 2026 with proper documentation placement.

powered bylight_fuzz_icon
37144330

*this image is generated using AI for illustrative purposes only.

Innovision Limited has re-filed regulatory documents with stock exchanges regarding the resignation of Ms. Sudha Hooda as Independent Director, following an exchange observation about missing documentation. The company submitted additional details on 08th April 2026 to BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Re-filing and Documentation Clarification

The company clarified that while the resignation letter was initially uploaded in the "Change in Management" section during the original filing on 07th April 2026, it was inadvertently not included under the "Disclosure for Director Resignation" section due to an oversight. The exchange observed this omission and requested proper documentation placement.

Filing Parameter: Details
Original Filing Date: 07th April 2026
Re-filing Date: 08th April 2026
Issue Identified: Missing resignation letter in disclosure section
Corrective Action: Re-filed PDF with resignation letter
Exchange Observation: Documentation placement oversight

Director Resignation Details

Ms. Sudha Hooda (DIN: 07982504) tendered her resignation through a letter dated 06th April 2026, citing other professional commitments and personal reasons. The resignation takes immediate effect from the date of submission, as confirmed in the regulatory filing signed by Company Secretary Jyoti Sachdeva.

Parameter: Details
Director Name: Ms. Sudha Hooda
DIN: 07982504
Resignation Date: 06th April 2026
Effective Date: Immediate effect
Reason: Professional commitments and personal reasons
Digital Signature Date: 08th April 2026

Committee Positions Impact

With Ms. Hooda's resignation, she will cease to hold the following positions within the company:

  • Chairman and Member of the Audit Committee
  • Member of the Nomination & Remuneration Committee

These changes in committee composition will require the company to reconstitute these important governance bodies in accordance with regulatory requirements.

Regulatory Compliance and Disclosures

The company has provided comprehensive disclosure as mandated under SEBI regulations, including detailed annexures as required under SEBI Master Circular dated November 11, 2024. Ms. Hooda confirmed that she holds no directorships in other listed companies and has no committee positions in listed entities.

Disclosure Requirement: Status
Listed Company Directorships: NIL
Committee Positions in Listed Companies: NIL
Material Reasons Confirmation: No other material reasons
Resignation Letter: Enclosed with re-filing

Board Acknowledgment

The Board of Directors has placed on record its appreciation for the valuable contribution and guidance provided by Ms. Sudha Hooda during her association with the company as an Independent Director. The resignation letter and detailed regulatory disclosures have been properly submitted to both BSE Limited and National Stock Exchange of India Limited as required under listing regulations. Company Secretary Jyoti Sachdeva (M. No-A22176) digitally signed the official communication on 08th April 2026 on behalf of Innovision Limited.

How quickly will Innovision Limited reconstitute its Audit Committee and Nomination & Remuneration Committee to meet regulatory compliance requirements?

What impact might the loss of an experienced Independent Director have on Innovision's corporate governance ratings and investor confidence?

Will Innovision face any regulatory penalties or increased scrutiny from exchanges due to the initial documentation filing oversight?

like15
dislike

Innovision Limited Schedules Board Meeting on April 13, 2026 for Q3FY26 Financial Results Review

1 min read     Updated on 08 Apr 2026, 07:54 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Innovision Limited has announced a board meeting for April 13, 2026, to review and approve unaudited financial results for Q3FY26 and nine months ended December 31, 2026. The meeting follows regulatory compliance under SEBI guidelines, with trading window restrictions in place for designated persons since March 23, 2026, remaining closed until 48 hours after audited results declaration for the year ended March 31, 2026.

powered bylight_fuzz_icon
37203863

*this image is generated using AI for illustrative purposes only.

Innovision Limited has formally notified stock exchanges about an upcoming board meeting to review its quarterly financial performance, marking a key milestone in the company's regulatory compliance schedule.

Board Meeting Details

The company has scheduled a board of directors meeting for Monday, April 13, 2026, in compliance with Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The meeting agenda includes specific items related to financial reporting and corporate governance.

Meeting Parameter: Details
Date: Monday, April 13, 2026
Primary Agenda: Unaudited Financial Results Review
Reporting Period: Q3FY26 and Nine Months Ended December 31, 2026
Results Type: Standalone and Consolidated

Key Agenda Items

The board will primarily focus on two main areas during the scheduled meeting. The directors will consider and approve the unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2026, along with the Limited Review Report from statutory auditors. Additionally, the meeting will address any other matters that may require board attention.

Trading Window Restrictions

In accordance with regulatory requirements, Innovision Limited has implemented trading restrictions for designated persons. The trading window for dealing in company securities has been closed for designated persons and their immediate relatives since March 23, 2026, which coincides with the company's listing date.

Trading Window Details: Information
Closure Date: March 23, 2026
Applicable To: Designated Persons and Immediate Relatives
Reopening: 48 hours after audited results declaration
Results Reference: Quarter and Year ended March 31, 2026

Regulatory Compliance

The announcement demonstrates the company's adherence to multiple regulatory frameworks. The notification complies with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and follows the company's Code of Conduct alongside SEBI (Prohibition of Insider Trading) Regulations, 2015. The company has made this intimation available on its official website and has formally notified both BSE Limited and National Stock Exchange of India Limited about the scheduled meeting.

How might Innovision's Q3FY26 performance impact its stock price trajectory following the results announcement?

What strategic initiatives could Innovision announce alongside its quarterly results to drive future growth?

Will the company's recent listing status influence investor expectations for its first major quarterly disclosure?

like15
dislike

More News on Innovision